Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 277

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Nuclear factor-kappa B and its role in inflammatory lung disease

Alharbi, Khalid Saad, Fuloria, Neeraj Kumar, Fuloria, Shivkanya, Rahman, Sk Batin, Al-Malki, Waleed Hassan, Javed Shaikh, Mohammad Arshad, Thangavelu, Lakshmi, Singh, Sachin K., Rama Raju Allam, Venkata Sita, Jha, Niraj Kumar, Chellappan, Dinesh Kumar, Dua, Kamal, Gupta, Gaurav·2021·Chemico-Biological Interactions

Abstract

Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion, growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric transcription factor. Inflammation is a key component of many common respiratory disorders, including asthma, COPD, bronchiectasis, and acute respiratory distress syndrome. Many basic transcription factors are found in NF-κB, which is a member of the Rel protein family. Five members of this family c-REL, NF-κB2 (p100/p52), RelA (p65), NF-κB1 (p105/p50), RelB, and RelA (p65) produce 5 transcriptionally active molecules. Proinflammatory cytokines, T lymphocyte, and B lymphocyte cell mitogens, lipopolysaccharides, bacteria, viral proteins, viruses, double-stranded RNA, oxidative stress, physical exertion, various chemotherapeutics are the stimulus responsible for NF-κB activation. NF-κB act as a principal component for several common respiratory illnesses, such as asthma, lung cancer, pulmonary fibrosis, COPD as well as infectious diseases like pneumonia, tuberculosis, COVID-19. Inflammatory lung disease, especially COVID-19, can make NF-κB a key target for drug production.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cbi.2021.109568

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 62 references

Cited by

See all 277

Metadata

Authors
Alharbi, K. S., Fuloria, N. K., Fuloria, S., Rahman, S. B., Al-Malki, W. H., Javed Shaikh, M. A., Thangavelu, L., Singh, S. K., Rama Raju Allam, V. S., Jha, N. K., Chellappan, D. K., Dua, K., & Gupta, G.
Venue
Chemico-Biological Interactions
Publisher
Elsevier BV
Published
2021-08
Volume
345
Pages
109568
ISSN
0009-2797 (ISSN-L)
OpenAlex
W3176675725
Cited by
277
References
62
FWCI
15.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuclear factor-kappa B and its role in inflammatory lung disease. https://app.cochat.ai/papers/10.1016/j.cbi.2021.109568
The paper
Alharbi, K. S., Fuloria, N. K., Fuloria, S., Rahman, S. B., Al-Malki, W. H., Javed Shaikh, M. A., Thangavelu, L., Singh, S. K., Rama Raju Allam, V. S., Jha, N. K., Chellappan, D. K., Dua, K., & Gupta, G. (2021). Nuclear factor-kappa B and its role in inflammatory lung disease. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2021.109568

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.